Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution.
about
Double Superhelix Model of High Density LipoproteinApolipoprotein E isoforms and lipoprotein metabolismStructural basis for the recognition and cross-linking of amyloid fibrils by human apolipoprotein EIsolation, characterization, and stability of discretely-sized nanolipoprotein particles assembled with apolipophorin-IIIThe binding of apolipoprotein E to oligomers and fibrils of amyloid-β alters the kinetics of amyloid aggregation.Optimized negative staining: a high-throughput protocol for examining small and asymmetric protein structure by electron microscopy.A mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions.Decoding of lipoprotein-receptor interactions: properties of ligand binding modules governing interactions with apolipoprotein E.The helix bundle: a reversible lipid binding motifCongruency between biophysical data from multiple platforms and molecular dynamics simulation of the double-super helix model of nascent high-density lipoprotein.An optimized negative-staining protocol of electron microscopy for apoE4 POPC lipoproteinConformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles.Apolipoprotein E: from lipid transport to neurobiologyVLDL lipolysis products increase VLDL fluidity and convert apolipoprotein E4 into a more expanded conformation.The low resolution structure of ApoA1 in spherical high density lipoprotein revealed by small angle neutron scattering.High density lipoprotein structure-function and role in reverse cholesterol transport.Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer's disease.Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomersOptimized negative-staining electron microscopy for lipoprotein studies.Three-dimensional models of HDL apoA-I: implications for its assembly and function.Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizesα-Synuclein oligomers with broken helical conformation form lipoprotein nanoparticles.Versatility in ligand recognition by LDL receptor family proteins: advances and frontiers.Insight on the molecular envelope of lipid-bound apolipoprotein E from electron paramagnetic resonance spectroscopy.Biophysical analysis of progressive C-terminal truncations of human apolipoprotein E4: insights into secondary structure and unfolding properties.Characterization and purification of polydisperse reconstituted lipoproteins and nanolipoprotein particles.Nanobiotechnology applications of reconstituted high density lipoprotein.Interaction between VLDL and phosphatidylcholine liposomes generates new γ-LpE-like particles.Dissociation of apolipoprotein E oligomers to monomer is required for high-affinity binding to phospholipid vesicles.Interactions between lipid-free apolipoprotein-AI and a lipopeptide incorporating the RGDS cell adhesion motif.Quantifying size distributions of nanolipoprotein particles with single-particle analysis and molecular dynamic simulations.Atomistic Insights into Structural Differences between E3 and E4 Isoforms of Apolipoprotein E.
P2860
Q27657720-8C3A4446-7F21-4AC2-9FF8-9AC4CB0B8EEAQ28249988-A6A1920D-A85B-41AB-B94E-BA44A9CF7184Q28252183-F809F3F7-7190-4E18-A474-15FC1D758FB4Q28474859-8B7145F3-DD3A-45C9-88DB-EA7CC6EE00BEQ30032680-B2AB45A0-CED7-4DF8-8DCA-A0BBAC7E4EACQ30365949-0F888E64-CD29-4209-8EBC-455DE94AE6C9Q30402554-800EB301-F6CD-4727-BB25-7D8647CB769DQ30433192-8D22865E-7891-46F0-88BB-29706024D772Q33598704-968FD667-8E7D-4375-B1AA-243306FAF010Q33650108-9369F8FF-C69D-4EE8-8DB3-6C77AF51A9A2Q33784574-2DF1E295-F51F-4319-BA7B-6072B546EF1BQ34160333-60332730-50CC-4E4B-8AD6-5B9F2167BB18Q34497951-A9F7B820-CFCE-459F-A314-5753CB751209Q34559824-26752184-F2F5-485E-B8FF-2AD136E01022Q34752390-EB0D34EA-9DC8-4FE5-A22C-9747B3A1A852Q35547011-00328F9A-33F7-4F0A-AC7F-8B791B69162BQ36061394-8E71E58C-F039-435D-B2CF-AEE92545E6B1Q36145226-0F438CF3-B923-4503-9832-3DA8C87413ABQ36429042-0C6F7ED2-5EC1-4ED5-B360-DC6F711302E4Q36836020-B0C05AFA-C5E1-42B4-BF7E-6F1248683E0DQ36858436-BDF4AF3C-C4B4-426E-A8C9-66A703949135Q36929059-E47FBA14-6EB5-4CCF-9390-98A2460C80D3Q36942847-16134066-980A-4EE1-BBA0-90D89A26631AQ37149489-6C088303-C7D2-481D-B825-C5223E08C94AQ37216782-357B8AE3-88F4-425E-9B0F-9796CF8319F3Q37335401-0E634E52-E200-4B1E-9D72-6505A7DAE0FCQ37814488-6C34984B-243B-48C9-A2A4-0BAC236FE4D0Q41891287-C4E9D515-88A3-4FC2-872F-87FF642FE22DQ41973817-09FBC31D-7DF4-4D68-96A7-4EFDFF5E3F6DQ45839925-E7AA4CB4-77BF-403B-BF92-0CA29797A43CQ46651802-42E493EC-E161-4576-B72E-769F259A2639Q47270627-F30D5A4F-932A-4438-B87C-B30EBE0968FD
P2860
Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution.
@en
Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution.
@nl
type
label
Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution.
@en
Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution.
@nl
prefLabel
Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution.
@en
Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution.
@nl
P2093
P2860
P1476
Apolipoprotein E*dipalmitoylphosphatidylcholine particles are ellipsoidal in solution.
@en
P2093
Clare A Peters-Libeu
H Ewa Witkowska
Karl H Weisgraber
Steven C Hall
Yvonne Newhouse
P2860
P304
P356
10.1194/JLR.M600545-JLR200
P577
2007-02-17T00:00:00Z